A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer|Locally Advanced Breast Cancer
Sponsor: Hoffmann-La Roche